Hu I, Serna A, Everts S, Gungordu L, Schomakers B, Nollen E
Geroscience. 2025; .
PMID: 40085390
DOI: 10.1007/s11357-025-01599-5.
Pentak D, Kozik V, Zieba A, Pazdzior-Heiske M, Szymczyk A, Jampilek J
Pharmaceutics. 2025; 17(2).
PMID: 40006569
PMC: 11860059.
DOI: 10.3390/pharmaceutics17020202.
Shi X, Wang X, Jin L, Halakivi-Clarke L, Clarke R, Neuwald A
PLoS Comput Biol. 2025; 21(1):e1012750.
PMID: 39888956
PMC: 11819608.
DOI: 10.1371/journal.pcbi.1012750.
Das S, Samaddar S
Cancers (Basel). 2025; 17(2).
PMID: 39858036
PMC: 11764476.
DOI: 10.3390/cancers17020255.
Liu M, Zheng L, Zhang Y, Tian J
Sci Rep. 2025; 15(1):2856.
PMID: 39843552
PMC: 11754797.
DOI: 10.1038/s41598-025-87286-z.
Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer Therapeutics.
Czylkowska A, Pitucha M, Raducka A, Fornal E, Kordialik-Bogacka E, Scieszka S
Molecules. 2025; 30(1.
PMID: 39795184
PMC: 11721278.
DOI: 10.3390/molecules30010129.
Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation-dependent mechanisms.
Sun Y, Jenkins L, El Touny L, Zhu L, Yang X, Jo U
Sci Adv. 2025; 11(2):eads2919.
PMID: 39792662
PMC: 11721697.
DOI: 10.1126/sciadv.ads2919.
Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase.
Szponar J, Ciechanski E, Ciechanska M, Dudka J, Mandziuk S
Int J Mol Sci. 2025; 25(24.
PMID: 39769331
PMC: 11678604.
DOI: 10.3390/ijms252413567.
Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications.
Borella F, Fucina S, Seminara Y, Denti P, Ferraioli D, Bertero L
Curr Oncol. 2024; 31(12):8054-8074.
PMID: 39727717
PMC: 11674396.
DOI: 10.3390/curroncol31120594.
Ultrasound-triggered drug release and cytotoxicity of microbubbles with diverse drug attributes.
Chuang C, Lin C, Yeh C
Ultrason Sonochem. 2024; 112():107182.
PMID: 39631357
PMC: 11655813.
DOI: 10.1016/j.ultsonch.2024.107182.
The role of circRNAs in resistance to doxorubicin.
Sanati M, Ghafouri-Fard S
Cell Commun Signal. 2024; 22(1):572.
PMID: 39614315
PMC: 11607985.
DOI: 10.1186/s12964-024-01952-9.
Protein-free domains in native and ferroptosis-driven oxidized cell membranes: a molecular dynamics study of biophysical properties and doxorubicin uptake.
Shabanpour Y, Hajipour-Verdom B, Abdolmaleki P, Alipour M
Front Mol Biosci. 2024; 11:1494257.
PMID: 39611002
PMC: 11602475.
DOI: 10.3389/fmolb.2024.1494257.
Small Molecule Inhibitors of Topoisomerase I Identified by Machine Learning and In Vitro Assays.
Chadni S, Young M, Igorra P, Bhuiyan M, Kenyon V, Tse-Dinh Y
Int J Mol Sci. 2024; 25(22).
PMID: 39596331
PMC: 11594364.
DOI: 10.3390/ijms252212265.
Single-molecule FRET-based approach for protein-targeted drug discovery.
Kim Y, Kim S, Heo K, Lee S
Mol Cells. 2024; 47(12):100150.
PMID: 39549747
PMC: 11667156.
DOI: 10.1016/j.mocell.2024.100150.
Pharmacogenomics and Big Data in medical oncology: developments and challenges.
Marcu L, Marcu D
Ther Adv Med Oncol. 2024; 16:17588359241287658.
PMID: 39483136
PMC: 11526290.
DOI: 10.1177/17588359241287658.
Human Topoisomerase IIα Promotes Chromatin Condensation Via a Phase Transition.
Wu M, Beck C, Lee J, Fulbright Jr R, Jeong J, Inman J
bioRxiv. 2024; .
PMID: 39464128
PMC: 11507700.
DOI: 10.1101/2024.10.15.618281.
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG Treatment.
Min K, Zheng C, Kim S, Kim H, Lee M, Piao X
Int J Mol Sci. 2024; 25(20).
PMID: 39456941
PMC: 11508893.
DOI: 10.3390/ijms252011157.
Pharmacokinetic predictions of ROS-mediated targets and genotoxin combinations via multiple ligand simultaneous docking and ROS evaluation in vitro using HepG2 cell lines.
Sri Snehaa C, Issac P, Rajaguru P, Pugalenthi V
3 Biotech. 2024; 14(11):266.
PMID: 39411103
PMC: 11471743.
DOI: 10.1007/s13205-024-04109-0.
Aclarubicin Reduces the Nuclear Mobility of Human DNA Topoisomerase IIβ.
Morotomi-Yano K, Yano K
Int J Mol Sci. 2024; 25(19).
PMID: 39409010
PMC: 11476477.
DOI: 10.3390/ijms251910681.
Genome Instability Induced by Topoisomerase Misfunction.
Nitiss K, Bandak A, Berger J, Nitiss J
Int J Mol Sci. 2024; 25(19).
PMID: 39408578
PMC: 11477040.
DOI: 10.3390/ijms251910247.